Goldman Sachs’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.7M | Sell |
|
|||||
|
2025
Q1 | $5.44M | Sell |
|
|||||
|
2024
Q4 | $11.1M | Buy |
|
|||||
|
2024
Q3 | $14M | Buy |
|
|||||
|
2024
Q2 | $9.68M | Sell |
|
|||||
|
2024
Q1 | $14.6M | Buy |
|
|||||
|
2023
Q4 | $10.8M | Buy |
|
|||||
|
2023
Q3 | $7.5M | Sell |
|
|||||
|
2023
Q2 | $16.2M | Sell |
|
|||||
|
2023
Q1 | $23M | Buy |
|
|||||
|
2022
Q4 | $19M | Sell |
|
|||||
|
2022
Q3 | $31.9M | Buy |
|
|||||
|
2022
Q2 | $16.1M | Buy |
|
|||||
|
2022
Q1 | $9M | Sell |
|
|||||
|
2021
Q4 | $13.6M | Buy |
|
|||||
|
2021
Q3 | $5.03M | Sell |
|
|||||
|
2021
Q2 | $7.2M | Sell |
|
|||||
|
2021
Q1 | $33.4M | Buy |
|
|||||
|
2020
Q4 | $28.6M | Buy |
|
|||||
|
2020
Q3 | $4.53M | Buy |
|